The landscape of hematologic oncology is shifting at an unprecedented pace, driven by rapid advancements in immunotherapy, targeted small-molecule inhibitors, and the integration of artificial intelligence into diagnostic workflows. To ensure that frontline clinicians remain at the vanguard of these developments, the Lymphoma Research Foundation (LRF) has officially announced the launch of its 2026-27 Lymphoma Rounds series.
The inaugural event of this academic season is scheduled for Wednesday, September 10, 2026, from 7:00 PM to 9:00 PM ET. This virtual program serves as a critical nexus for physicians practicing in both high-acuity academic medical centers and community-based oncology clinics. By providing a platform for collaborative learning, the LRF aims to bridge the gap between burgeoning laboratory research and real-world clinical application.
The Core Mission: Bridging Academic and Community Care
At its inception, the Lymphoma Rounds series was designed with a singular, vital objective: to democratize access to cutting-edge lymphoma management strategies. While academic centers often have immediate access to the latest clinical trials, community practitioners are frequently the primary caregivers for the vast majority of lymphoma patients.
"The goal of these rounds is to ensure that geography does not dictate the quality of care a patient receives," says the program committee. By facilitating an interactive forum where physicians can dissect complex cases, share best practices, and debate the nuances of emerging therapies, the LRF fosters a cohesive national network of expertise. This year’s series promises to uphold that tradition, utilizing a virtual format to ensure that clinicians from across the country—regardless of their proximity to major research hubs—can participate in the exchange of high-level clinical knowledge.
Chronology and Program Evolution
The 2026-27 series marks a significant milestone in the evolution of LRF’s professional education initiatives. Following the success of previous years, the foundation has doubled down on its commitment to the "virtual-first" model.
Key Dates and Participation Milestones:
- September 10, 2026: Kick-off of the 2026-27 series.
- Pre-Registration Requirement: Interested healthcare professionals must register in advance to receive access credentials.
- One-Week RSVP Deadline: For pharmaceutical industry representatives and national exhibit sponsors, a strict RSVP deadline of one week prior to the event remains in place to facilitate logistics and virtual exhibit hall management.
- Ongoing Enrollment: The LRF encourages all attendees to subscribe to their official email updates, as the specific agenda for the September 10 session will be finalized and distributed in the weeks leading up to the event.
The transition to a digital-only format is not merely a logistical necessity but a strategic choice. By utilizing the Zoom platform, the LRF has successfully increased attendance numbers by eliminating travel barriers, allowing busy oncologists to balance their patient care duties with the requirements of professional development.
Clinical Focus and Educational Objectives
The Lymphoma Rounds are meticulously curated by a planning faculty comprised of some of the most respected names in hematology. The 2026-27 planning committee features Dr. Elizabeth Brém of the University of California, Irvine; Dr. James Gerson of the University of Vermont; and Dr. Paul S. Martin of the Fred Hutchinson Cancer Center/UW Medical Center, who serves as the LRF Advisory Board (LRAB) Co-Chair.
While the specific agenda for the September session is still being finalized, the program is designed to meet the rigorous standards of the University of Cincinnati, which serves as the provider for physician accreditation. The activity is designated for a maximum of 4.50 AMA PRA Category 1 Credits™.
Educational activities in this series are designed to help participants:
- Analyze the latest data on novel therapeutic agents, including CAR T-cell therapy updates and bispecific antibodies.
- Evaluate diagnostic challenges in sub-types of non-Hodgkin and Hodgkin lymphoma.
- Implement updated response criteria in daily practice to improve patient outcomes.
- Navigate the complexities of toxicity management and long-term survivorship.
Supporting the Ecosystem: The Role of Industry
The LRF acknowledges that the rapid development of oncology treatments is inextricably linked to the efforts of pharmaceutical partners. Consequently, Lymphoma Rounds provides a dedicated space for representatives from these organizations to engage with the physician community.
The program offers "Virtual Exhibit" opportunities, allowing companies to present their latest therapeutic data in a structured, professional setting. However, the LRF maintains a clear boundary between educational content and industry promotion. Representatives interested in sponsorship are required to contact the foundation directly to ensure their participation aligns with the LRF’s stringent health and safety policies and professional conduct guidelines. By maintaining these standards, the foundation ensures that the primary focus remains on the physician-patient relationship and the advancement of curative medicine.
Implications for Future Patient Care
The implications of this educational series extend far beyond the two-hour virtual meeting. For the practicing oncologist, the ability to engage with peers and thought leaders on a regular basis is essential.
The "Community-Academic" Feedback Loop
When a community physician presents a challenging case during the virtual rounds, the feedback from academic experts often informs immediate changes in the community setting. Conversely, the questions raised by community physicians—who often see a wider variety of patient presentations—help researchers in academic centers identify gaps in current treatment protocols or areas where real-world evidence is lacking.
The Power of Networking
The networking component of Lymphoma Rounds is perhaps its most underrated asset. The digital format facilitates breakout discussions and Q&A sessions where a physician from a rural clinic might gain the contact information of a specialist at a major research center. This type of horizontal collaboration is what the LRF believes will drive the next decade of success in lymphoma treatment.
How to Get Involved
For those planning to attend the September 10, 2026, event, the LRF recommends the following steps:
- Verify System Requirements: As this is a virtual event hosted on Zoom, attendees should test their audio and video configurations well in advance. The LRF provides links to Zoom’s support documentation to ensure a seamless experience.
- Monitor Official Channels: Because the agenda is dynamic, registrants should keep an eye on their inbox for the official program release.
- Stay Informed: The foundation’s Health and Safety Policy page serves as a comprehensive guide for all professional programs. Even in a virtual space, the LRF maintains a code of conduct that ensures all educational interactions remain respectful, ethical, and patient-centered.
- Registration: Interested parties should access the registration form via the official LRF portal.
Conclusion: A Commitment to Excellence
As we move further into 2026, the complexity of managing lymphoma continues to grow. From the molecular characterization of tumors to the personalization of chemotherapy regimens, the burden of knowledge on the modern physician is immense. By providing a structured, accredited, and highly collaborative environment, the Lymphoma Rounds program stands as a testament to the Lymphoma Research Foundation’s dedication to the medical community.
The September 10th program is not just another webinar; it is a vital checkpoint in the ongoing fight against lymphoma. By bringing together the best minds in the field, the LRF is ensuring that when a patient walks into a clinic—whether in a major city or a small town—their physician is equipped with the most advanced, evidence-based tools available to provide the highest standard of care.
For those interested in becoming a program supporter, the LRF invites inquiries at their dedicated support email. Together, through continuous education and professional collaboration, the medical community moves closer to the ultimate goal: a world without lymphoma.
